Views | |
---|---|
PP2A inhibition determines poor outcome and doxorubicin resistance in early breast cancer and its activation shows promising therapeutic effects. | 244 |
June 2024 | July 2024 | August 2024 | September 2024 | October 2024 | November 2024 | December 2024 | |
---|---|---|---|---|---|---|---|
PP2A inhibition determines poor outcome and doxorubicin resistance in early breast cancer and its activation shows promising therapeutic effects. | 6 | 0 | 8 | 8 | 0 | 2 | 0 |
Views | |
---|---|
rincon-onc-pp2a.pdf | 547 |
Views | |
---|---|
United States | 132 |
France | 28 |
Germany | 26 |
Spain | 10 |
Belgium | 7 |
United Kingdom | 5 |
Ireland | 5 |
Australia | 4 |
Czech Republic | 4 |
Italy | 4 |
Views | |
---|---|
Fairfield | 21 |
Mountain View | 17 |
Ashburn | 12 |
Cambridge | 10 |
San Ramon | 10 |
Menlo Park | 9 |
Barcelona | 6 |
Ann Arbor | 5 |
Dublin | 5 |
San Diego | 5 |